FDA Inspection 1297066 — John B. Buse, M.D., Ph.D.
The FDA completed an inspection of John B. Buse, M.D., Ph.D. on December 18, 2025 in Chapel Hill, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 18, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chapel Hill, NC (United States)
Additional Details
Clinical Investigator (CI)